NAPLEX Practice Exam 2025 – Comprehensive Test Preparation

Question: 1 / 1820

Which drug is indicated to improve walking in MS patients?

Ampyra

Ampyra is a drug that is indicated to improve walking in MS patients. Ampyra, also known as dalfampridine, is a potassium channel blocker that helps to improve nerve conduction and function. It is specifically approved to improve walking speed in MS patients. The other options, Benlysta, Ponvory, and Kesimpta, are not indicated for this purpose. Benlysta is used to treat lupus, while Ponvory is used to treat relapsing forms of MS, and Kesimpta is used to treat relapsing forms of MS as well. These drugs may have other benefits for MS patients, but they are not specifically indicated to improve walking. Therefore, Ampyra is the correct answer.

Get further explanation with Examzify DeepDiveBeta

Benlysta

Ponvory

Kesimpta

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy